Nanox to Participate in Three Upcoming November 2020 Investor Conferences

Rhea-AI Summary

NANO-X IMAGING LTD (NASDAQ: NNOX) announced participation in three upcoming investor conferences. Key events include the Berenberg US CEO Conference on November 12, 2020, at 9:00 AM ET, the Jefferies Virtual London Healthcare Conference on November 17, 2020, at 5:35 AM ET, and the Canaccord Genuity Virtual MedTech & Diagnostics Forum on November 19, 2020, at 9:00 AM ET. Each event will have a live webcast available for registration. The company aims to leverage its innovative medical imaging technology for affordable healthcare solutions.

NEVE ILAN, Israel & TAIPEI, Taiwan, Nov. 05, 2020 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today that Ran Poliakine, Chairman and Chief Executive Officer and other members of the leadership team will be participating in three upcoming investor conferences.

Presentation details:

Event: Berenberg US CEO Conference 2020
Date: Thursday, November 12, 2020
Time: 9:00 AM ET

Event: Jefferies Virtual London Healthcare Conference
Date: Tuesday, November 17, 2020
Time: 5:35 AM ET (10:35 AM GMT)
Webcast: Interested participants may register for the live webcast here.

Event: Canaccord Genuity Virtual MedTech & Diagnostics Forum
Date: Thursday, November 19, 2020
Time: 9:00 AM ET
Webcast: Interested participants may register for the live webcast here.

The webcasts will be archived on the Nanox website and available for replay for a period of 90 days.

About Nanox:

Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications. Nanox believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all. For more information, please visit www.nanox.vision.

Contact:

Itzhak Maayan
Nanox Imaging
IR@nanox.vision

Bob Yedid
LifeSci Advisors
646-597-6989
bob@lifesciadvisors.com

FAQ

What is the schedule for NANO-X IMAGING LTD's upcoming investor conferences?

NANO-X IMAGING LTD will participate in the Berenberg US CEO Conference on November 12, 2020, at 9:00 AM ET, Jefferies Virtual London Healthcare Conference on November 17, 2020, at 5:35 AM ET, and Canaccord Genuity Virtual MedTech & Diagnostics Forum on November 19, 2020, at 9:00 AM ET.

How can I access the webcast for NANO-X IMAGING LTD's investor conferences?

Interested participants can register for the webcasts of NANO-X IMAGING LTD's investor conferences. Registration links are provided in the company's press release.

What is the focus of NANO-X IMAGING LTD during the investor conferences?

NANO-X IMAGING LTD will present its innovative medical imaging technology, aiming to discuss potential collaborations for affordable healthcare solutions.

Who will represent NANO-X IMAGING LTD at the investor conferences?

Ran Poliakine, Chairman and CEO of NANO-X IMAGING LTD, along with other members of the leadership team, will represent the company at the conferences.

What is the significance of the events for NANO-X IMAGING LTD?

These conferences provide NANO-X IMAGING LTD an opportunity to showcase its advancements in medical imaging technology and engage with potential investors.